All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
XPH total return snapshot: XPH returned +32.02% over the past year and +14.18% YTD, with dividends reinvested. Since Jun. 22, 2006, XPH is up +469.70% in nominal total return, or +8.96%/yr, and is currently −13.83% below its total-return high on Aug. 19, 2026.
Data ending Thu Oct. 1, 2026
| Thu 2006-06-22💬 to Thu 2026-10-01 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| XPH × |
+469.70%
+8.96%/yr |
+8.05%/yr
R2=0.744 |
||||
| SPDR S&P Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Thu 2006-06-22💬 to Thu 2026-10-01 |
Start
Value |
End
Value |
|---|---|---|
| XPH × |
$10,000.00
2006-06-22 |
$56,969.83
2026-10-01 |
| YTD | YoY | |
|---|---|---|
| XPH × | +14.18% | +32.02% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| XPH × |
−13.83%
on 2026-10-01 from 2026-08-19 peak |
−48.03%
on 2020-03-23 from 2015-07-22 peak |
| Period ending Thu 2026-10-01 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| XPH × | +32.02% |
+46.02% +20.84%/yr |
+65.85% +18.37%/yr |
+41.55% +7.20%/yr |
+58.74% +4.73%/yr |
| Year | XPH |
|---|---|
| 2026 (YTD) | +14.18% |
| 2025 | +31.61% |
| 2024 | +4.94% |
| 2023 | +2.97% |
| 2022 | −9.84% |
| 2021 | −10.54% |
| 2020 | +14.68% |
| 2019 | +25.61% |
| 2018 | −15.32% |
| 2017 | +12.05% |
| 2016 | −23.20% |
| 2015 | +1.65% |
| 2014 | +29.52% |
| 2013 | +60.84% |
| 2012 | +10.91% |
| 2011 | +12.73% |
| 2010 | +22.46% |
| 2009 | +27.66% |
| 2008 | −8.99% |
| 2007 | −1.02% |
| 2006 | +11.12% |
